title: Novel data in metastatic breast cancer.
authors.affiliation: Weill Cornell Medical College, New York, New York.
authors.forename: Linda T
authors.initials: LT
authors.lastname: Vahdat
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001940:Breast / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D055808:Drug Discovery; D000068338:Everolimus; D005260:Female; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use; D009362:Neoplasm Metastasis / Q000188:drug therapy* / Q000473:pathology; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism; D011804:Quinolines / Q000627:therapeutic use; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D018841:HSP90 Heat-Shock Proteins; D018796:Immunoconjugates; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011804:Quinolines; C551271:glembatumumab vedotin; D000068338:Everolimus; D011065:Poly(ADP-ribose) Polymerases; C487932:neratinib; D020123:Sirolimus